Reconstruction of the sphenoid sinus erosion or dehiscence after treatment of unruptured intracavernous aneurysms with flow diverter stents.

Aneurysm Angiography CT Flow Diverter

Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
16 Aug 2023
Historique:
received: 23 06 2023
accepted: 03 08 2023
medline: 17 8 2023
pubmed: 17 8 2023
entrez: 16 8 2023
Statut: aheadofprint

Résumé

Intracavernous carotid aneurysms (ICCAs) are rare, frequently asymptomatic, with a low rupture risk, which, however, can lead to life-threatening epistaxis. The aim of this study was to assess the effect of the treatment of asymptomatic ICCAs with flow diverters (FD) on sphenoid bone erosion or dehiscence in a selected cohort of patients. We retrospectively reviewed all asymptomatic ICCAs with sphenoid bone erosion or dehiscence detected on cone beam CT (CBCT) and treated with FD between December 2018 and December 2022. Patients were followed-up with CBCT and bone reconstruction was blindly evaluated by two interventional neuroradiologists and classified as unchanged, partial, or complete. A total of 10 patients (women: 90%, mean age 58 years) treated with an FD for an asymptomatic ICCA with associated sphenoid bone erosion or dehiscence were included in this cohort. Sphenoid bone erosion was present in seven patients and dehiscence was observed in the remaining three. After treatment with FD, complete reconstruction of the sphenoid sinus wall occurred in seven cases, and partial reconstruction in two cases. Sphenoid bone erosion remained unchanged after treatment in only one patient. The decision to treat asymptomatic and unruptured ICCAs remains challenging due to their benign natural history and low hemorrhagic risk. The presence of sphenoid sinus erosion or dehiscence should not be overlooked since it could be considered as an indication for prophylactic treatment of life-threatening epistaxis. The mechanisms of bone erosion by the aneurysm and of reconstruction after treatment are still to be fully elucidated.

Sections du résumé

BACKGROUND BACKGROUND
Intracavernous carotid aneurysms (ICCAs) are rare, frequently asymptomatic, with a low rupture risk, which, however, can lead to life-threatening epistaxis. The aim of this study was to assess the effect of the treatment of asymptomatic ICCAs with flow diverters (FD) on sphenoid bone erosion or dehiscence in a selected cohort of patients.
METHODS METHODS
We retrospectively reviewed all asymptomatic ICCAs with sphenoid bone erosion or dehiscence detected on cone beam CT (CBCT) and treated with FD between December 2018 and December 2022. Patients were followed-up with CBCT and bone reconstruction was blindly evaluated by two interventional neuroradiologists and classified as unchanged, partial, or complete.
RESULTS RESULTS
A total of 10 patients (women: 90%, mean age 58 years) treated with an FD for an asymptomatic ICCA with associated sphenoid bone erosion or dehiscence were included in this cohort. Sphenoid bone erosion was present in seven patients and dehiscence was observed in the remaining three. After treatment with FD, complete reconstruction of the sphenoid sinus wall occurred in seven cases, and partial reconstruction in two cases. Sphenoid bone erosion remained unchanged after treatment in only one patient.
CONCLUSIONS CONCLUSIONS
The decision to treat asymptomatic and unruptured ICCAs remains challenging due to their benign natural history and low hemorrhagic risk. The presence of sphenoid sinus erosion or dehiscence should not be overlooked since it could be considered as an indication for prophylactic treatment of life-threatening epistaxis. The mechanisms of bone erosion by the aneurysm and of reconstruction after treatment are still to be fully elucidated.

Identifiants

pubmed: 37586819
pii: jnis-2023-020734
doi: 10.1136/jnis-2023-020734
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Tiago Lorga (T)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France tiagomlorga@gmail.com.
Neuroradiology, Centro Hospitalar Universitário de Lisboa Central EPE, Lisboa, Portugal.

Silvia Pizzuto (S)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.

Oguzhan Coskun (O)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.

Alessandro Sgreccia (A)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.

Martino Cavazza (M)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.
Diagnostic and Interventional Radiology, University Hospital Arcispedale Sant'Anna of Ferrara, Cona, Italy.

Mohammad Habibur Rahman (MH)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.
Interventional Neurology, National Institute of Neurosciences and Hospital, Sher-E-Bangla Nagar, Bangladesh.

Georges Rodesch (G)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.

Federico Di Maria (F)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.

Arturo Consoli (A)

Diagnostic and Interventional Neuroradiology, Hôpital Foch, Suresnes, France.
Versailles Saint-Quentin-en-Yvelines University, Versailles, France.

Classifications MeSH